Financhill
Sell
30

HART Quote, Financials, Valuation and Earnings

Last price:
$31.19
Seasonality move :
0.56%
Day range:
$31.10 - $31.10
52-week range:
$28.56 - $34.43
Dividend yield:
1.19%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
1K
1-year change:
9.13%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HART
NYLI Healthy Hearts ETF
-- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- --
IXJ
iShares Global Healthcare ETF
-- -- -- -- --
JDOC
JPMorgan Healthcare Leaders ETF
-- -- -- -- --
THNR
Amplify Weight Loss Drug & Treatment ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HART
NYLI Healthy Hearts ETF
$31.10 -- -- -- $0.06 1.19% --
AGNG
Global X Aging Population ETF
$30.63 -- -- -- $0.10 0.74% --
IXJ
iShares Global Healthcare ETF
$86.93 -- -- -- $0.62 1.48% --
JDOC
JPMorgan Healthcare Leaders ETF
$51.65 -- -- -- $0.33 5.45% --
THNR
Amplify Weight Loss Drug & Treatment ETF
$23.11 -- -- -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HART
NYLI Healthy Hearts ETF
-- 0.784 -- --
AGNG
Global X Aging Population ETF
-- 1.009 -- --
IXJ
iShares Global Healthcare ETF
-- 0.894 -- --
JDOC
JPMorgan Healthcare Leaders ETF
-- 0.904 -- --
THNR
Amplify Weight Loss Drug & Treatment ETF
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HART
NYLI Healthy Hearts ETF
-- -- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- -- --
IXJ
iShares Global Healthcare ETF
-- -- -- -- -- --
JDOC
JPMorgan Healthcare Leaders ETF
-- -- -- -- -- --
THNR
Amplify Weight Loss Drug & Treatment ETF
-- -- -- -- -- --

NYLI Healthy Hearts ETF vs. Competitors

  • Which has Higher Returns HART or AGNG?

    Global X Aging Population ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HART
    NYLI Healthy Hearts ETF
    -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- --
  • What do Analysts Say About HART or AGNG?

    NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than Global X Aging Population ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than Global X Aging Population ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HART
    NYLI Healthy Hearts ETF
    0 0 0
    AGNG
    Global X Aging Population ETF
    0 0 0
  • Is HART or AGNG More Risky?

    NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.

  • Which is a Better Dividend Stock HART or AGNG?

    NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HART or AGNG?

    NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HART
    NYLI Healthy Hearts ETF
    -- -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- -- --
  • Which has Higher Returns HART or IXJ?

    iShares Global Healthcare ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HART
    NYLI Healthy Hearts ETF
    -- -- --
    IXJ
    iShares Global Healthcare ETF
    -- -- --
  • What do Analysts Say About HART or IXJ?

    NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than iShares Global Healthcare ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HART
    NYLI Healthy Hearts ETF
    0 0 0
    IXJ
    iShares Global Healthcare ETF
    0 0 0
  • Is HART or IXJ More Risky?

    NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.919%.

  • Which is a Better Dividend Stock HART or IXJ?

    NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. iShares Global Healthcare ETF offers a yield of 1.48% to investors and pays a quarterly dividend of $0.62 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HART or IXJ?

    NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HART
    NYLI Healthy Hearts ETF
    -- -- -- --
    IXJ
    iShares Global Healthcare ETF
    -- -- -- --
  • Which has Higher Returns HART or JDOC?

    JPMorgan Healthcare Leaders ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HART
    NYLI Healthy Hearts ETF
    -- -- --
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- --
  • What do Analysts Say About HART or JDOC?

    NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than JPMorgan Healthcare Leaders ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HART
    NYLI Healthy Hearts ETF
    0 0 0
    JDOC
    JPMorgan Healthcare Leaders ETF
    0 0 0
  • Is HART or JDOC More Risky?

    NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HART or JDOC?

    NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. JPMorgan Healthcare Leaders ETF offers a yield of 5.45% to investors and pays a quarterly dividend of $0.33 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HART or JDOC?

    NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HART
    NYLI Healthy Hearts ETF
    -- -- -- --
    JDOC
    JPMorgan Healthcare Leaders ETF
    -- -- -- --
  • Which has Higher Returns HART or THNR?

    Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to NYLI Healthy Hearts ETF's net margin of --. NYLI Healthy Hearts ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HART
    NYLI Healthy Hearts ETF
    -- -- --
    THNR
    Amplify Weight Loss Drug & Treatment ETF
    -- -- --
  • What do Analysts Say About HART or THNR?

    NYLI Healthy Hearts ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that NYLI Healthy Hearts ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe NYLI Healthy Hearts ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HART
    NYLI Healthy Hearts ETF
    0 0 0
    THNR
    Amplify Weight Loss Drug & Treatment ETF
    0 0 0
  • Is HART or THNR More Risky?

    NYLI Healthy Hearts ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HART or THNR?

    NYLI Healthy Hearts ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 1.19%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NYLI Healthy Hearts ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HART or THNR?

    NYLI Healthy Hearts ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. NYLI Healthy Hearts ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, NYLI Healthy Hearts ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NYLI Healthy Hearts ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HART
    NYLI Healthy Hearts ETF
    -- -- -- --
    THNR
    Amplify Weight Loss Drug & Treatment ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
60
QMCO alert for Dec 26

Quantum [QMCO] is up 49.62% over the past day.

Buy
53
ARQQ alert for Dec 26

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock